Quantum Shift, or Better Arithmetic? Private Industry Crosses Half of India's R&D

The Lift Line

A private majority in a research system that spends 0.84 per cent of GDP tells you who is paying. It does not yet tell you that enough is being paid.

Why This Editorial Matters for Your Exam

Research and development spending appears in GS3 answers as a single number, usually “India spends about 0.7 per cent of GDP on R&D, against 2 per cent in China”. Both halves of that sentence are now out of date, and the second is the kind of stale figure that costs marks. This editorial supplies the current figures and, more usefully, a way of interrogating them: the distinction between a share and a level, and between a change in behaviour and a change in measurement.

It also pairs directly with the Gaganyaan qualification milestones in today’s news, which are publicly funded, long-horizon capability of exactly the kind the private majority does not finance.

GS Paper 3: Science and technology, developments and their applications and effects in everyday life; indigenisation of technology and developing new technology; Indian economy and mobilisation of resources.

Background and Context

The trigger is the R&D Statistics tabled in the Rajya Sabha on 31 July 2026, which record private industry at 51.8 per cent of gross expenditure on research and development in 2023-24, and gross expenditure at about 0.84 per cent of GDP in FY24.

India’s research system was constructed in the decades after independence around public institutions with distinct mandates.

This architecture delivered genuine achievements, the Green Revolution research base, an indigenous nuclear and space capability, and a defence research establishment. What it did not do was pull private industry into research, because the state was simultaneously the funder, the performer and often the customer.

The Analysis

1. Crossing 50 per cent changes the character of the system, not just its size. The share matters because of what the private sector funds. Firms fund research nearest to commercialisation, because they capture the returns. That is simultaneously the strength and the limit of private funding: it converts knowledge into products efficiently, and it systematically underfunds research whose returns are distant, uncertain or non-appropriable.

2. The denominator is the binding constraint. At 0.84 per cent of GDP, India’s total research effort remains well below the long-stated national goal of 2 per cent and far below the comparator economies. A share can rise for two very different reasons: the numerator grows, or the denominator of the other component shrinks. If the private share rose partly because public research funding stagnated in real terms, the composition improved for a reason that should worry rather than reassure.

3. Measurement is doing some of the work, and nobody knows how much. As the statistical system widens its survey coverage of private firms, and as expenditure previously classified as design, testing, engineering or production is reclassified as research, the measured private share rises with no change in behaviour whatsoever. This is not a hypothetical concern for a series that has recently expanded its coverage of the corporate sector.

4. But the reclassification argument has a limit. Measurement error correcting in one direction across several successive years is better evidence that the earlier series understated private research than that the present one overstates it. The expansion of global capability centres, pharmaceutical and vaccine development, and semiconductor design in India is visible independently of the statistics.

5. What the private majority cannot do. Gaganyaan’s human-rating programme, in today’s news, is the illustration. Certifying a launch vehicle to carry humans has no commercial return for a decade or more and no appropriable intellectual property at the end of it. No private funder finances that. Neither does basic research in mathematics, nor long-horizon agricultural breeding, nor most of what a country needs in a pandemic. A private majority is a good outcome only if public funding holds its position in absolute terms.

Data and Institutions Vault

Prelims-grade facts:

• Private industry share of GERD: 51.8 per cent in 2023-24, the first year above half
• GERD as a share of GDP: about 0.84 per cent in FY24
• Source: R&D Statistics tabled in the Rajya Sabha on 31 July 2026
• India’s long-stated national goal: 2 per cent of GDP
• Industry-funded share in innovation-led economies: roughly 60 to 70 per cent
• Public research institutions: CSIR (1942), DRDO (1958), DAE (1954), ICAR (1929), ISRO (1969)
• Anusandhan National Research Foundation (ANRF) was established by the ANRF Act, 2023, replacing the Science and Engineering Research Board (SERB), with a mandate to seed and fund research including in state universities, and an intent to draw a substantial share of its corpus from non-government sources
• Department of Science and Technology (DST) compiles the R&D Statistics series
• India’s rank in the Global Innovation Index has risen substantially over the last decade, driven more by market sophistication and knowledge outputs than by research expenditure

Watch the trap: the widely quoted figure “India spends 0.7 per cent of GDP on R&D” is now out of date, and so is any claim that the government funds the majority. Both were true and are no longer. Equally, do not write that India has reached the 2 per cent goal; 0.84 per cent is not 2 per cent.

The Debate

Argument FOR reading this as a genuine turning point. The structure of research funding has inverted after seven decades, in the direction every innovation-led economy has taken. The change is visible in the real economy through global capability centres, pharmaceutical development and chip design, not only in a statistical table. Demand-pulled research converts into products in a way that state-pushed research historically has not in India, and the shift should be welcomed rather than qualified into insignificance.

Argument AGAINST. The milestone is a ratio, and a ratio can improve without anything improving. At 0.84 per cent of GDP the absolute effort is modest, and if the private share rose partly because public spending stagnated, the composition improved for the wrong reason. A material and unquantified part of the movement is reclassification. Announcing a “quantum shift” on these numbers risks the conclusion that the state’s job is now done.

Balanced verdict. The shift is real and its direction is right, but it is a diagnostic and not an achievement. Composition matters only at an adequate level of total spending. The correct policy response to a private majority is therefore more public research funding rather than less, redirected towards the basic and long-horizon end where the private majority will never go, together with methodological transparency so that the reclassification component can be separately estimated.

How to Think About This

The transferable pattern here is: separate the ratio from the level, and the measurement from the behaviour.

Whenever a statistic is presented as a breakthrough, ask two questions before accepting it.

Is this a share or a quantity? A share can rise because the numerator grew or because the other component fell. The two have opposite policy implications, and the headline never distinguishes them.

Did the world change, or did the counting change? Expanded survey coverage, redefined categories and reclassified expenditure all move measured quantities without moving real ones.

This pattern applies far beyond research spending. It is the same question to ask of a fall in the poverty headcount after a change in the consumption survey design, of a rise in forest cover after a change in the definition of forest, and of an improvement in a learning outcome after a change in the sampling frame.

Diagram-in-Words

STATE-DOMINATED SYSTEM (historic)
Public funding  →  Public institutions perform  →  Capability built
                                                   ↓
                                          Weak commercialisation
                                          (no private demand pull)

TRANSITION (2023-24: private share crosses 51.8%)
Private funding ─┐
                 ├→ Research performed →  Products, near-term returns
Public funding  ─┘

                 BUT: GERD still only 0.84% of GDP
                 AND: part of the private rise = reclassification

THE GAP THAT REMAINS
Basic research ─── no appropriable return ───→ private capital will not fund
Long-horizon capability (e.g. human-rating a launch vehicle)
                 ↓
        LEVER: public funding must RISE, not fall, and
               concentrate where private funding cannot go (ANRF)

Takeaway Box

Lift line for an answer:

India’s research problem was never only who pays. It was how little was paid in total, and that has not yet changed.

Prelims hooks: private share 51.8 per cent (2023-24); GERD 0.84 per cent of GDP (FY24); R&D Statistics tabled 31 July 2026; ANRF Act, 2023 replaced SERB; CSIR 1942, DAE 1954, DRDO 1958, ISRO 1969, ICAR 1929.

Ethics and interview angle: a government that publishes a statistic showing improvement has an interest in not publishing the methodology change that produced part of it. What obligation does a statistical system owe to the public beyond accuracy in the number itself?

PYQ linkage: UPSC has repeatedly examined the gap between India’s scientific output and its innovation performance, including questions on why publicly funded research does not translate into commercial technology, and on the role of the private sector in research. This editorial supplies current figures for exactly that answer.

Probable question: “A rising private share in research funding is a diagnostic, not an achievement.” Critically examine with reference to India’s gross expenditure on research and development.

Sources: The Hindu, Department of Science and Technology, PIB

Source: Quantum Shift, or Better Arithmetic? Private Industry Crosses Half of India's R&D — Ujiyari.com | Free UPSC & State PCS Editorial Analysis